Related Experiment Video
Updated: Aug 6, 2026

Rotating the Intraocular Lens to Prevent Posterior Capsular Opacification in Cataract Surgeries
Published on: July 7, 2023
Clinical features and intraocular lens material properties for posterior capsule opacification risk prediction
Xianglin He1, Su Li1, Zeen Lv1
1Eye Center, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang Provincial Key Laboratory of Ophthalmology, Zhejiang Provincial Clinical Research Center for Eye Diseases, Zhejiang Provincial Engineering Institute on Eye Diseases, Hangzhou, 310009, P. R. China.
Abstract:
Posterior Capsule Opacification (PCO) remains a prevalent long-term complication following surgery for cataract, the world's primary blinding disease, significantly compromising visual outcomes. Although intraocular lens (IOL) material is a recognized risk factor, large-scale datasets linking granular material properties with longitudinal clinical outcomes remain scarce. Here, we present a real-world dataset comprising clinical records from 16,970 patients (22,709 eyes) who underwent cataract surgery at the Eye Center of the Second Affiliated Hospital of Zhejiang University School of Medicine in China between January 2019 and December 2022, with follow-up extending to May 2025. The dataset integrates patient demographics, systemic and ocular comorbidities, and surgical parameters. Crucially, these clinical variables are augmented with detailed IOL physicochemical specifications, covering both macroscopic design features and constituent chemical monomers (e.g., HEMA, EA). All records were extracted from electronic health records, rigorously anonymized, and technically validated against established epidemiological patterns. This resource provides a foundation for investigating the multifactorial determinants of PCO, facilitating analyses ranging from clinical risk assessment to the evaluation of biomaterial biocompatibility.
Related Concept Videos
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...

